Equity Profile

TMO

Thermo Fisher Scientific Inc.

Health CareLife Sciences Tools & Services$175.7B

Apr23Thu

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:00 AM EDT

Thermo Fisher Scientific Beats on EPS, Stock Up 0.0%

Metric	Actual	Expected	Surprise
EPS	$5.44	N/A	+4.68%
Revenue	N/A	N/A	N/A

management commentary, guidance changes, and full analysis available with Pro.

Thermo Fisher Scientific Beats on EPS, Stock Up 0.0%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$5.44	N/A	+4.68%
Revenue	N/A	N/A	N/A

Management Commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction while acknowledging market challenges. They noted positive trends in customer demand.

Management highlighted strong demand in key segments.

They emphasized ongoing investments in innovation.

There was a focus on maintaining operational efficiency.

What It Means

Thermo Fisher Scientific's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reaction remained flat, suggesting that investors may be cautious or awaiting further details on revenue performance and future guidance. The lack of revenue data and guidance may lead to uncertainty in the market moving forward.

Company Snapshot

Thermo Fisher Scientific (TMO) is a leading company in the health care sector, specializing in life sciences tools and services. Their products and services are critical for laboratories and research facilities, making them a key player in advancements in health care and scientific research.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial indicator of profitability and can influence investor sentiment significantly.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+3.04%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q4 2025, Thermo Fisher reported an EPS of $6.57, exceeding estimates by 2.13%. However, the stock saw a decline of 2.61% the following day, indicating mixed market reactions.

Management Promises & Guidance

Continued focus on innovation in life sciences tools.
Commitment to expanding global market presence.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Overall expectations for Thermo Fisher's upcoming earnings are cautious, given the lack of specific guidance and mixed reactions to previous results.

Bull Case

If the company can deliver strong EPS and revenue growth, it may signal robust demand for its products, leading to positive market sentiment.

Bear Case

Conversely, any signs of slowing growth or margin compression could lead to a negative reaction from investors, especially given the recent stock performance.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's track record of beating EPS estimates, this figure will be crucial in determining market sentiment.

What are the expectations for revenue growth in key segments?

Understanding revenue growth in critical areas will help assess the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for revenue growth in emerging markets, which could significantly boost overall performance.

Supporting Evidence

Previous quarters have shown consistent EPS beats, indicating stronger underlying demand than anticipated.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

The company's commitment to innovation could drive unexpected revenue streams.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching EPS and revenue growth, as these metrics will indicate the company's health and future direction.

Bull Confirmed If

An EPS of $6.80 or higher would confirm strong performance and growth.

Bear Confirmed If

An EPS below $6.30 could signal potential challenges in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±4.47%

Historical Avg

±4.5%

In line with history

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.

Options are pricing ±4.5% while TMO has averaged ±4.5% over the last 8 prints — setup is roughly in line with history.

Detail

30d HV

31.7%

Calls (35K)P/C Ratio: 0.96Puts (34K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Thermo Fisher beats expectations, history suggests a potential stock increase of around +2.14%, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating an average drop of around -0.71%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Insights into market demand in emerging regions.
3Details on operational efficiencies and cost management.
4Management's outlook on industry trends and competitive landscape.
5Any changes in guidance for the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Apr20

CLFReported

Cleveland-Cliffs Inc.

RecapView

Apr20

BOHReported

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a crucial indicator of profitability and can influence investor sentiment significantly.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+3.04%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q4 2025, Thermo Fisher reported an EPS of $6.57, exceeding estimates by 2.13%. However, the stock saw a decline of 2.61% the following day, indicating mixed market reactions.

Management Promises & Guidance

Continued focus on innovation in life sciences tools.
Commitment to expanding global market presence.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Overall expectations for Thermo Fisher's upcoming earnings are cautious, given the lack of specific guidance and mixed reactions to previous results.

Bull Case

If the company can deliver strong EPS and revenue growth, it may signal robust demand for its products, leading to positive market sentiment.

Bear Case

Conversely, any signs of slowing growth or margin compression could lead to a negative reaction from investors, especially given the recent stock performance.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's track record of beating EPS estimates, this figure will be crucial in determining market sentiment.

What are the expectations for revenue growth in key segments?

Understanding revenue growth in critical areas will help assess the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for revenue growth in emerging markets, which could significantly boost overall performance.

Supporting Evidence

Previous quarters have shown consistent EPS beats, indicating stronger underlying demand than anticipated.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

The company's commitment to innovation could drive unexpected revenue streams.

Key Risk

If revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching EPS and revenue growth, as these metrics will indicate the company's health and future direction.

Bull Confirmed If

An EPS of $6.80 or higher would confirm strong performance and growth.

Bear Confirmed If

An EPS below $6.30 could signal potential challenges in maintaining profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±4.47%

Historical Avg

±4.5%

In line with history

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings report.

Options are pricing ±4.5% while TMO has averaged ±4.5% over the last 8 prints — setup is roughly in line with history.

Detail

30d HV

31.7%

Calls (35K)P/C Ratio: 0.96Puts (34K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Thermo Fisher beats expectations, history suggests a potential stock increase of around +2.14%, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating an average drop of around -0.71%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Insights into market demand in emerging regions.
3Details on operational efficiencies and cost management.
4Management's outlook on industry trends and competitive landscape.
5Any changes in guidance for the upcoming quarters.